Coronary Artery Disease

Arterioscler Thromb Vasc Biol. 2020 Jul;40(7):e185-e192. doi: 10.1161/ATVBAHA.120.313608. Epub 2020 Jun 24.

Authors

Harsh Agrawal^#¹, Ho-Hin K Choy^#², Jason Liu², Matthew Auyoung², Michelle A Albert¹

Affiliations

¹ From the Center for the Study of Adversity and Cardiovascular Disease (NURTURE Center), Division of Cardiology, Department of Medicine, University of California San Francisco (H.A., M.A.A.).
² Division of Cardiology, Department of Medicine, California Pacific Medical Center, San Francisco (H.-h.K.C., J.L., M.A.).

^# Contributed equally.

PMID: 32579480
DOI: 10.1161/ATVBAHA.120.313608

No abstract available

Keywords: apolipoproteins; atherosclerosis; cardiovascular diseases; coronary artery disease; triglycerides.

Publication types

Review

MeSH terms

Animals
Anticholesteremic Agents / therapeutic use
Autoimmunity
Biomarkers / blood
Coronary Artery Disease* / blood
Coronary Artery Disease* / drug therapy
Coronary Artery Disease* / genetics
Coronary Artery Disease* / immunology
Dyslipidemias / blood
Dyslipidemias / genetics
Ezetimibe / therapeutic use
Genetic Predisposition to Disease
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Inflammation / blood
Inflammation / immunology
Inflammation Mediators / blood
Lipids / blood
Periodicals as Topic
Phenotype
Risk Factors

Substances

Anticholesteremic Agents
Biomarkers
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Inflammation Mediators
Lipids
Ezetimibe